Skip to main content
. 2012 Aug 10;7(8):e42913. doi: 10.1371/journal.pone.0042913

Figure 6. Rapamycin reduces elevated VEGF and HIF-1 levels in hemangioma endothelial cells.

Figure 6

A: Immunoblotting showing the effects of rapamycin on p70S6K phosphorylation, HIF-1α expression and VEGF-A165 expression in normal (HDMEC) or hemangioma (EC2, EC17B, EC21A) endothelial cell lysates. B and C: Luminex analysis showing reduced expression of HIF-1α (B) and VEGF-A165 (C) in hemangioma endothelial cells treated with rapamycin. Data represent mean (n = 3)±SD; *P<0.05 compared to vehicle.